NEWS | BEAM Alliance

NEWS

Motif Bio Presents Iclaprim Data at ESCMID/ASM Conference

Motif Bio Presents Iclaprim Data at ESCMID/ASM Conference

Motif Bio plc (AIM/NASDAQ: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced that iclaprim data are being presented at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID)/American Society for Microbiology (ASM) Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance being held in Lisbon, Portugal, September 4-7, 2018.

Full PR available here